Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds virus or component thereof
Reexamination Certificate
2007-08-02
2010-06-01
Chen, Stacy B (Department: 1648)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Binds virus or component thereof
C424S224100
Reexamination Certificate
active
07727532
ABSTRACT:
Human monoclonal antibodies that specifically bind to rabies virus, antigen binding portions thereof, and methods of making and using such antibodies and antigen binding portions thereof for treating rabies virus in a subject, are provided herein.
REFERENCES:
patent: 5840300 (1998-11-01), Williams et al.
patent: 2003/0165507 (2003-09-01), Hooper et al.
patent: WO-95/09249 (1995-04-01), None
patent: WO-01/88132 (2001-11-01), None
patent: WO-02/094880 (2002-11-01), None
patent: WO-2005/002511 (2005-01-01), None
patent: WO-2005/023849 (2005-03-01), None
Rudikoff et al. PNAS USA, 1982, 79:1979-1983.
MacCallum et al. J. Mol. Biol. 1996, 262:732-745.
De Pascalis et al. The Journal of Immunology, 2002, 169:3076-3084.
Casset et al. BBRC, 2003, 307:198-205.
Prehaud, Christophe et al., “Immunogenic and Protective Properties of Rabies Virus Glycoprotein Expressed by Baculovirus Vectors,”Virology, vol. 173:390-399 (1989).
Sloan, Susan E. et al., “Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates,”Vaccine, vol. 25:2800-2810 (2007).
Benmansour, A. et al., “Antigenicity of Rabies Virus Glycoprotein,”Journal of Virology, vol. 65(8):4198-4203 (1991).
Champion, J.M. et al., “The development of monoclonal human rabies virus-neutralizing antibodies as a substitute for pooled human immune globulin in the prophylactic treatment of rabies virus exposure,”Journal of Immunological Methods, vol. 235:81-90 (2000).
Cox, James H. et al., “Rabies Virus Glycoprotein, II. Biological and Serological Characterization,”Infection and Immunity, vol. 16(3):754-759 (1977).
Dietzschold, Bernhard et al., “Biological Characterization of Human Monoclonal Antibodies to Rabies Virus,”Journal of Virology, vol. 64(6):3087-3090 (1990).
Hanlon, C.A. et al., “The incurable wound revisited: progress in human rabies prevention?”Vaccine, vol. 19:2273-2279 (2001).
Irie, Takashi et al., “Studies on the Escape Mutants of Rabies Virus Which Are Resistant to Neutralization by a Highly Conserved Conformational Epitope-Specific Monoclonal Antibody #1-46-12,”Microbiol. Immunol., vol. 46(7):449-461 (2002).
Kankanamge, Pushpa Jenette et al., “Mapping of the Low pH-Sensitive Conformational Epitope of Rabies Virus Glycoprotein Recognized by a Monoclonal Antibody #1-30-44,”Microbiol. Immunol., vol. 47 (7):507-519 (2003).
Marissen, Wilfred E. et al., “Novel Rabies Virus-Neutralizing Epitope Recognized by Human Monoclonal Antibody: Fine Mapping and Escape Mutant Analysis,”Journal of Virology, vol. 79(8):4672-4678 (2005).
Rando, R.F. et al., “Production of Human Monoclonal Antibodies Against Rabies Virus,”Current Topics in Microbiology and Immunology, vol. 187:195-205 (1994).
Ray, K. et al., “Selection of single chain variable fragments (scFv) against the glycoprotein antigen of the rabies virus from a human synthetic scFv phage display library and their fusion with the Fc region of human IgG1,”Clin. Exp. Immunol., vol. 125:94-101 (2001).
International Search Report for Application No. PCT/US2006/003644, dated Jul. 12, 2006.
International Preliminary Report on Patentability for Application No. PCT/US2006/003644, dated Feb. 22, 2007.
Written Opinion for Application No. PCT/US2006/003644, dated Jul. 12, 2006.
EMBL AC M18517, “Human (fetal) Ig rearranged H-chain VDJ-region mRNA, clone 56P1,” (2007).
Geneseq AC ABZ59699, “Anti-Trail-R antibody related clone 0304 nucleotide SEQ ID No:30,” (2003).
Schroeder, Harry W. Jr. et al., “Early Restriction of the Human Antibody Repertoire,”Science, vol. 238(4828):791-793 (1987).
Ambrosino Donna M.
Babcock Gregory J.
Mandell Robert
Rupprecht Charles
Sloan Susan
Centers for Disease Control and Prevention
Chen Stacy B
Lahive & Cockfield LLP
Remillard, Esq. Jane E.
Sloper, Esq. Jilly Gorny
LandOfFree
Human antibodies against rabies and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human antibodies against rabies and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human antibodies against rabies and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4229325